DNA-cloaked nanoparticles for tumor microenvironment-responsive activation

• Published in: Journal of controlled release Vol. 350; pp. 448 - 459
• Main Authors: Kim, Dongyoon, Byun, Junho, Kim, Se Ik, Chung, Hyun Hoon, Kim, Yong-Wan, Shim, Gayong, Oh, Yu-Kyoung
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01-10-2022
• Subjects: DNA nanothread; DNA-cloaked nanoparticles; Reactive oxygen species; Selective activation; Tumor microenvironment; Reactive oxygen species; DNA-cloaked nanoparticles; Selective activation; Tumor microenvironment; DNA nanothread
• ISSN: 0168-3659; 1873-4995
• DOI: 10.1016/j.jconrel.2022.08.044

Although progress has been made in developing tumor microenvironment-responsive delivery systems, the list of cargo-releasing stimuli remains limited. In this study, we report DNA nanothread-cloaked nanoparticles for reactive oxygen species (ROS)-rich tumor microenvironment-responsive delivery systems. ROS is well known to strongly induce DNA fragmentation via oxidative stress. As a model anticancer drug, hydrophobic omacetaxine was entrapped in branched cyclam ligand-modified nanoparticles (BNP). DNA nanothreads were prepared by rolling-circle amplification and complexed to BNP, yielding DNA nanothread-cloaked BNP (DBNP). DBNP was unmasked by DNA nanothread-degrading ROS and culture supernatants of LNCaP cells. The size and zeta potential of DBNP were changed by ROS. In ROShigh LNCaP cells, but not in ROSlow fibroblast cells, the uptake of DBNP was higher than that of other nanoparticles. Molecular imaging revealed that DBNP exhibited greater distribution to tumor tissues, compared to other nanoparticles. Ex vivo mass spectrometry-based imaging showed that omacetaxine metabolites were distributed in tumor tissues of mice treated with DBNP. Intravenous administration of DBNP reduced the tumor volume by 80% compared to untreated tumors. Profiling showed that omacetaxine treatment altered the transcriptional profile. These results collectively support the feasibility of using polymerized DNA-masked nanoparticles for selective activation in the ROS-rich tumor microenvironment.
[Display omitted]